mibefradil has been researched along with Nephrosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruneval, P; Duong Van Huyen, JP; Heudes, D; Qiu, C; Roeckel, A; Roux, S | 1 |
1 other study(ies) available for mibefradil and Nephrosclerosis
| Article | Year |
|---|---|
Mibefradil prevents L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Antagonism; Enzyme Inhibitors; Hypertension; Mibefradil; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR | 1999 |